These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18939494)

  • 21. DOI and booster vaccination--dealing with the issue at practice level in France.
    Poubanne Y
    Vet Microbiol; 2006 Oct; 117(1):86-92. PubMed ID: 16920281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular immunity as a potential cause of local reactions to booster vaccination with diphtheria and tetanus toxoids and acellular pertussis antigens.
    Scheifele DW; Ochnio JJ; Halperin SA
    Pediatr Infect Dis J; 2009 Nov; 28(11):985-9. PubMed ID: 19755930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How do we manage vaccinations in patients with inflammatory bowel disease?
    Esteve Comas M; Loras Alastruey C; Fernandez-Bañares F
    Dig Dis; 2009; 27(3):370-4. PubMed ID: 19786767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine.
    Bovier PA; Bock J; Ebengo TF; Frösner G; Glaus J; Herzog C; Loutan L
    J Med Virol; 2010 Oct; 82(10):1629-34. PubMed ID: 20827757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination.
    Sam MR; Shokrgozar MA; Shokri F
    Intervirology; 2008; 51(2):87-95. PubMed ID: 18477849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
    Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
    Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
    Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hopf bifurcation in epidemic models with a time delay in vaccination.
    Khan QJ; Greenhalgh D
    IMA J Math Appl Med Biol; 1999 Jun; 16(2):113-42. PubMed ID: 10399309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B vaccination. Indications of the post-vaccine serologic test and booster doses].
    Pallás Alvarez JR; Gómez Holgado MS; Llorca Díaz J; Delgado Rodríguez M
    Rev Esp Salud Publica; 2000; 74(5-6):475-82. PubMed ID: 11217237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers.
    Kaml M; Weiskirchner I; Keller M; Luft T; Hoster E; Hasford J; Young L; Bartlett B; Neuner C; Fischer KH; Neuman B; Würzner R; Grubeck-Loebenstein B
    Vaccine; 2006 Nov; 24(47-48):6808-11. PubMed ID: 16872725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled field trials with oral and nasal immunization against tetanus in humans.
    Mayr A; Baljer G; Baljer E; Sailer J
    Dev Biol Stand; 1978; 41():31-8. PubMed ID: 753660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.